Top

Published in:

01-12-2011 | Gastrointestinal Oncology

Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence

Authors: John Spiliotis, MD, Eugenia Halkia, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2011

Excerpt

Peritoneal carcinomatosis is a deadly disease. Current evidence suggests that after standardized gastrectomy with D2 lymphadenectomy resulting in a complete tumor resection (R0) and adjuvant chemotherapy, peritoneal recurrence is the most common fatal treatment failure.1 Several traditional clinicopathologic features, including serosal invasion, have been reported to predict peritoneal dissemination, but there is still no robust predictor of this type of recurrence. …

Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.PubMedCrossRef

Sun Z, Xu YY, Wang ZN, et al. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery. Ann Surg Oncol. 2011;18:1068–80.PubMedCrossRef

Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59:579–85.PubMedCrossRef

Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.PubMedCrossRef

Roukos DH. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. 2011;11(2):81–92.PubMedCrossRef

Roukos DH. Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices. 2010;7(6):723–6.PubMedCrossRef

Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics. 2010;11(8):1039–43.PubMedCrossRef

Roukos DH. Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med. 2010;4(4):583–6.PubMedCrossRef

Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per Med. 2010;7(4):347–50.CrossRef

10.

Roukos DH, Katsios C, Liakakos T. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn. 2010;10(5):541–5.PubMedCrossRef

Title: Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence
Authors: John Spiliotis, MD
Eugenia Halkia, MD
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue Special Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-1851-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Slow Progress in Predicting and Preventing Fatal Gastric Cancer Peritoneal Recurrence

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 3/2011

Assessment of ACS NSQIP’s Predictive Ability for Adverse Events After Major Cancer Surgery

Strategy for Nonresponder Breast Cancer Patients to Neoadjuvant Treatment

Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: Proceed with Caution

Comparing Prediction Models: The Distinction Between Clinical and Statistical Significance

F18-FDG PET/CT and Differentiated Thyroid Carcinoma: A Critical and Still Debated Issue

Reply to Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery